Jeffrey A Johnson
Overview
Explore the profile of Jeffrey A Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
455
Citations
17447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei X, Lipscomb J, Tino A, Cong M, Ruone S, Bentz M, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772184
The HIV integrase inhibitor, dolutegravir (DTG), in the absence of eliciting integrase (int) resistance, has been reported to select mutations in the virus 3'-polypurine tract (3'-PPT) adjacent to the 3'-LTR...
2.
Soprovich A, Short H, Ali A, Brower K, Ohinmaa A, Johnson J
Health Sci Rep
. 2025 Jan;
8(1):e70308.
PMID: 39741745
Background And Aims: Patient-reported outcome measures (PROMs) are increasingly used in primary care practices; however, the broad characteristics of this population pose unique challenges. Generic PROMs (e.g., EQ-5D-5L) measure general...
3.
Al Sayah F, Jin X, Short H, McClure N, Ohinmaa A, Johnson J
Value Health
. 2024 Dec;
28(3):470-476.
PMID: 39694263
Objectives: We aimed to provide a comprehensive summary, synthesis, and appraisal of minimally important difference (MID) estimates for EQ-5D instruments. Methods: We conducted a systematic search using relevant terms related...
4.
Al Sayah F, Alam A, Short H, Ohinmaa A, Lahtinen M, Malo S, et al.
Qual Life Res
. 2024 Nov;
34(1):219-230.
PMID: 39487883
Purpose: To present EQ-5D-5L population norms for the general adult population in Alberta, Canada. Methods: We analyzed data from 11 population-based surveys conducted in Alberta between 2012 and 2021. By...
5.
Ye M, Vena J, Shen-Tu G, Johnson J, Eurich D
Healthcare (Basel)
. 2024 Oct;
12(19).
PMID: 39408189
Objective: The objective is to characterize the impact of COVID-19 on major healthcare for diabetes, including hospitalization, emergency department (ED) visits and primary care visits in Alberta, Canada. Methods: Participants...
6.
MacGowan R, Chavez P, Dana R, Hannah M, Raiford J, Caldwell J, et al.
J Acquir Immune Defic Syndr
. 2024 Sep;
97(2):133-141.
PMID: 39250647
Introduction: We evaluated internet platforms for distributing HIV self-tests (HIVSTs) to Black or African American (Black) and Hispanic or Latino men who have sex with men (MSM) and transgender women...
7.
Johnson J, Li J, Politch J, Lipscomb J, Tino A, DeFelice J, et al.
J Infect Dis
. 2024 Jul;
230(1):78-85.
PMID: 39052738
As use of human immunodeficiency virus (HIV) integrase strand transfer inhibitors (INSTI) increases and formulations are being developed for maintenance therapies and chemoprophylaxis, assessing virus suppression under INSTI-based regimens in...
8.
Di Germanio C, Deng X, Grebe E, Johnson J, Masciotra S, Busch M, et al.
J Clin Virol
. 2024 Jun;
174:105708.
PMID: 38941925
The Asanté HIV-1 Rapid Recency assay's 'verification' line detected HIV infection a median of 18 days later than a nucleic acid detection assay and performed similarly to 19 other existing...
9.
Elliott E, Smith D, Lipscomb J, Banini B, Meurer L, Vanderford T, et al.
Open Forum Infect Dis
. 2024 Apr;
11(4):ofae170.
PMID: 38585186
The acute retroviral syndrome may present with diverse systemic manifestations and laboratory abnormalities. Here we present a rare case of primary human immunodeficiency virus (HIV) infection causing severe acute hepatitis....
10.
Lester S, Stumpf M, Freeman B, Mills L, Schiffer J, Semenova V, et al.
Access Microbiol
. 2024 Mar;
6(2).
PMID: 38482357
Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) is a novel human coronavirus that was identified in 2019. SARS-CoV-2 infection results in an acute, severe respiratory disease called coronavirus disease...